Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Messick

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Diagnostic Microbiology and Infectious Disease|December 24, 1997
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococciC R Messick, S L Pendland
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|October 1, 1994
Drug-lab interactions: implications for nutrition support. Acetylcysteine interference with urine ketone testB J Holcombe, C R Messick
American Journal of Hospital Pharmacy|August 1, 1994
Update on Clostridium difficile-induced colitis, Part 2C M Reinke, C R Messick
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|July 1, 1996
Therapeutic modalities for mechanical cleansing of the colonC R Messick, L H Danziger
American Journal of Hospital Pharmacy|July 15, 1994
Update on Clostridium difficile-induced colitis, Part 1C M Reinke, C R Messick
Diagnostic Microbiology and Infectious Disease|November 21, 1998
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococciC R Messick, J Woodward, S L Pendland
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinationsC R Messick, K A Rodvold, S L Pendland
Cornea|July 1, 1997
Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosisR G Fiscella, M Moshifar, C R Messick, et al.
The Annals of Pharmacotherapy|April 9, 1998
Levofloxacin and sparfloxacin: new quinolone antibioticsS J Martin, J M Meyer, S K Chuck, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 1999
In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitisC R Messick, S L Pendland, M Moshirfar, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Diagnostic Microbiology and Infectious Disease|December 24, 1997
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococciC R Messick, S L Pendland
Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|October 1, 1994
Drug-lab interactions: implications for nutrition support. Acetylcysteine interference with urine ketone testB J Holcombe, C R Messick
American Journal of Hospital Pharmacy|August 1, 1994
Update on Clostridium difficile-induced colitis, Part 2C M Reinke, C R Messick
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|July 1, 1996
Therapeutic modalities for mechanical cleansing of the colonC R Messick, L H Danziger
American Journal of Hospital Pharmacy|July 15, 1994
Update on Clostridium difficile-induced colitis, Part 1C M Reinke, C R Messick
Diagnostic Microbiology and Infectious Disease|November 21, 1998
In vitro activity of RPR 106972 alone and in combination with vancomycin, ampicillin, and gentamicin against multidrug-resistant enterococciC R Messick, J Woodward, S L Pendland
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinationsC R Messick, K A Rodvold, S L Pendland
Cornea|July 1, 1997
Polyhexamethylene biguanide (PHMB) in the treatment of experimental Fusarium keratomycosisR G Fiscella, M Moshifar, C R Messick, et al.
The Annals of Pharmacotherapy|April 9, 1998
Levofloxacin and sparfloxacin: new quinolone antibioticsS J Martin, J M Meyer, S K Chuck, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 1999
In-vitro activity of polyhexamethylene biguanide (PHMB) against fungal isolates associated with infective keratitisC R Messick, S L Pendland, M Moshirfar, et al.
Pageof 2